FREESTONE CAPITAL HOLDINGS, LLC – Revance Therapeutics, Inc. Transaction History
FREESTONE CAPITAL HOLDINGS, LLC portfolio value:
$817,000
portfolio value
FREESTONE CAPITAL HOLDINGS, LLC quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 399K | $27 | 30.25K | |
| Q2 2022 | share | Increase | +2.02% | 599 shares | -160K | $13.82 | 30.25K |
| Q1 2022 | share | 0.00% | 0 shares | 94K | $19.5 | 29.65K | |
| Q4 2021 | share | Increase | +1.31% | 383 shares | -332K | $16.49 | 29.65K |
| Q3 2021 | share | 0.00% | 0 shares | -52K | $27.86 | 29.27K | |
| Q2 2021 | share | 0.00% | 0 shares | 50K | $29.64 | 29.27K | |
| Q1 2021 | share | 0.00% | 0 shares | -11.62K | $27.95 | 29.27K | |
| Q4 2020 | share | Increase | 0.00% | 29.27K shares | 829.62K | $28.34 | 29.27K |